Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways

Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kim

Clin Mol Hepatol. 2022;28(4):827-840. Published online June 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0068

View: 7656 Download: 405 Web of Science: 20 Crossref: 20

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B

Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clin Mol Hepatol. 2021;27(2):295-304. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0216

View: 5818 Download: 212 Web of Science: 20 Crossref: 24

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis

Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon

Clin Mol Hepatol. 2015;21(2):141-149. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.141

View: 9574 Download: 137 Web of Science: 44 Crossref: 40

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B

In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim

Clin Mol Hepatol. 2015;21(1):32-40. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.32

View: 9744 Download: 88 Web of Science: 13 Crossref: 12

Review

NADPH oxidase mediated oxidative stress in hepatic fibrogenesis

Yong-Han Paik, David A. Brenner

Clin Mol Hepatol. 2011;17(4):251-257. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.251

View: 9875 Download: 78 Crossref: 40

3

Serum hyaluronic acid Level: Correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model

Moon Young Kim, M.D., Soon Koo Baik, M.D., Yoon Ok Jang, M.D., Ki Tae Suk, M.D., Jae Woo Kim, M.D., Hyun Soo Kim, M.D., Mi Yun Cho, M.D. Sun Joo Choi, M.D. Soon Ho Um, M.D. Kwang-Hyub Han, M.D.

Clin Mol Hepatol. 2008;14(2):159-167. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.159

View: 4866 Download: 54 Crossref: 6

2

Role of Liver Biopsy in the Assessment of Hepatic Fibrosis -Its Utility and Limitations

So Young Jin

Clin Mol Hepatol. 2007;13(2):138-145. Published online January 1, 1970

View: 2722 Download: 33

Clinical Application of Non-invasive Diagnosis for Hepatic Fibrosis

Sung Won Cho , Jae Youn Cheong

Clin Mol Hepatol. 2007;13(2):129-137. Published online January 1, 1970

View: 3414 Download: 65

7

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003;37: 87-95

Geun Youn Gwok , Jung Hwan Yoon

Clin Mol Hepatol. 2003;9(2):145-146. Published online January 1, 1970

View: 2415 Download: 18

3

The Diagnostic Value of Serum Hyaluronic Acid, 7S Domain of Type IV Collagen and AST/ALT Ratio as Markers of Hepatic Fibrosis in Chronic Hepatitis B and Cirrhosis Patients

Jin Hyung Park, M.D., Chang Kun Park, M.D., Eun Soo Kim, M.D., Soo Young Park, M.D., Chang Min Jo, M.D., Won Young Tak, M.D., Young Oh Kweon, M.D., Sung Kook Kim, M.D. and Yong Whan Choi, M.D.

Clin Mol Hepatol. 2003;9(2):79-88. Published online January 1, 1970

View: 2988 Download: 29

4

Two Cases of Congenital Hepatic Fibrosis with Polycystic Kidney Disease

Dong Hyun Lee,Ok Nyu Kong,Ji Young Kim,Chan Won Park,Jae Hyeon Moon,Dae Gun Nam,Hyung Jun Chu,Dae Hwan Kang,Geun Am Song,Mong Cho,Ung Suk Yang

Clin Mol Hepatol. 2001;7(4):485-490. Published online January 1, 1970

View: 2485 Download: 16

3

Changes of Propranolol Pharmacokinetic Parameters According to Hepatic Fibrotic Severity in CCl₄-Treated Rats

Mun Su Kang, M.D., Chang Ok Yoon, M.D., Jai Won Byun, M.D., Oh Young Lee, M.D. Byung Chul Yoon, M.D., Joon Soo Hahm, M.D., Ju Seop Kang, M.D.*, Min Ho Lee, M.D.

Clin Mol Hepatol. 2001;7(2):181-188. Published online January 1, 2000

View: 2353 Download: 16

Protective Effect of Pentoxifylline and Ciprofloxacin on Dimethylnitrosamine-induced Hepatic Fibrosis in Rats

Kang Suek Suh,Chang Hun Lee,Mee Young Sol,Sun Kyung Lee

Clin Mol Hepatol. 2001;7(1):34-46. Published online January 1, 2000

View: 2406 Download: 19

1

Pharmacologic Therapy of Hepatic Fibrosis

Dong Joon Kim

Clin Mol Hepatol. 2001;7(1):6-11. Published online January 1, 2000

View: 2206 Download: 12

3

The Clinical Significance of Serum Hyaluronic Acid and Type IV Collagen Level in Chronic Hepatitis and Early Liver Cirrhosis

Joo Hyun Sohn, M.D., Young Woo Sohn, M.D., Dong Soo Han, M.D. Yong Cheol Jeon, M.D., Choon Suhk Kee, M.D., Won Mi Lee*, M.D. Se Jin Jang*, M.D. and Yong Wook Park*, M.D.

Clin Mol Hepatol. 1999;5(3):190-199. Published online January 1, 2000

View: 2554 Download: 16

Lipid Peroxidation in Chronic Liver Diseases Type B

Kyung Chul Kim , Kwan Sik Lee , Kwang Hyub Han , Won Choi , Chae Yoon Chon , Sang In Lee , Young Myung Moon , Jin Kyung Kang , In Suh Park , Hye Young Kim

Clin Mol Hepatol. 1997;3(1):40-49.

View: 2473 Download: 18

1 |

Viewed By 4932	MAFLD: How is it different from NAFLD?
Viewed By 4828	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4725	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4444	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4402	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search